![]() Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201461986520P external-priority Priority to CN201580030255.5A priority Critical patent/CN106659801B/en Priority to MX2016014247A priority patent/MX2016014247A/en Priority to KR1020217009876A priority patent/KR102275513B1/en Priority to SG11201608953WA priority patent/SG11201608953WA/en Priority to RS20210270A priority patent/RS61516B1/en Priority to DK15774735.3T priority patent/DK3137114T3/en Priority to ES15774735T priority patent/ES2856927T3/en Priority to BR112016025291A priority patent/BR112016025291A2/en Priority to SI201531546T priority patent/SI3137114T1/en Priority to EP20159103.9A priority patent/EP3711780A3/en Priority to LTEP15774735.3T priority patent/LT3137114T/en Priority to JP2017509591A priority patent/JP6629837B2/en Priority to RU2016143119A priority patent/RU2708075C2/en Priority to EP15774735.3A priority patent/EP3137114B8/en Application filed by Pfizer Inc., Stemcentrx, Inc. ![]() Priority date (The priority date is an assumption and is not a legal conclusion. ( en Inventor Marc Isaac Damelin Puja Sapra Alexander John BANKOVICH Scott J. Google Patents WO2015168019A2 - Anti-ptk7 antibody-drug conjugates ![]() ![]() WO2015168019A2 - Anti-ptk7 antibody-drug conjugates ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |